Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Phytolacca decandra (synonym Phytolacca americana), commonly known as pokeweed, is a perennial plant utilized in homeopathic medicine and ethnopharmacology. In homeopathy, it is frequently administered in ultra-diluted forms (such as 12c or 12CH) for conditions including nocturnal bruxism in children, mastitis, and chronic rheumatism. Research into its phytochemical constituents, particularly triterpenoids like oleanolic acid and betulinic acid derivatives, has demonstrated potential anticancer activity in various cell lines, including melanoma, lung, and breast cancer. These effects are primarily mediated through the induction of mitochondria-dependent apoptosis, reactive oxygen species (ROS) generation, and the activation of caspase-3 signaling pathways. While traditionally used for its anti-inflammatory and lymphatic effects, the plant contains toxic alkaloids and glycoproteins, requiring careful preparation and standardized dosing in clinical applications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on phytolacca decandra.